According to a new report, published by KBV research, The Global Orthopedic Implants Market size is expected to reach $45.7 billion by 2028, rising at a market growth of 6.6% CAGR during the forecast period.
The Knee Implants segment acquired maximum revenue share in the Global Orthopedic Implants Market by Product in 2021 thereby, achieving a market value of $15 billion by 2028. The increasing senior population, growing rates of chronic illnesses including diabetes and obesity, and unhealthy lifestyle choices are accelerating knee therapy use. The rising demand has forced developers of knee implants to create new biomaterials and enhance the performance of current materials in terms of corrosion resistance, biocompatibility, and reduced wear.
The Orthopedic Clinics segment is showcasing a CAGR of 6.8% during (2022 - 2028). The preference for orthopedic clinics has shifted away from hospitals as a result of improvements in clinics' facility needs. As a result, the availability of emergency minimally invasive operations, sophisticated implants, and shorter hospital stays are projected to drive the market during the projection period.
The North America market dominated the Global Orthopedic Implants Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $19.2 billion by 2028. The Europe market is exhibiting a CAGR of 6.4% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 7.5% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/orthopedic-implants-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Johnson & Johnson (DePuy Synthes), Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew PLC, ConMed Corporation, B. Braun Melsungen AG (Aesculap, Inc.), Colfax Corporation, NuVasive, Inc., and Arthrex, Inc.
By Product
By End-use
By Geography
Companies Profiled
Unique Offerings 
